CAS 55379-75-4

Benzenepropanenitrile,a-amino-

Description:

Benzenepropanenitrile, α-amino- (CAS 55379-75-4) is an organic compound characterized by its structure, which includes a benzene ring attached to a propanenitrile group with an amino functional group. This compound typically exhibits properties associated with both aromatic and aliphatic compounds, such as moderate solubility in polar solvents and a tendency to participate in electrophilic aromatic substitution reactions. The presence of the amino group can impart basicity and reactivity, allowing it to form various derivatives through reactions like acylation or alkylation. Additionally, the nitrile group contributes to the compound's polarity and can participate in nucleophilic addition reactions. Benzenepropanenitrile, α-amino- may be utilized in the synthesis of pharmaceuticals, agrochemicals, or as an intermediate in organic synthesis due to its functional groups. Safety data should be consulted for handling, as compounds with amino and nitrile groups can pose health risks if not managed properly.

Formula: C₉H₁₀N₂

Synonyms:

• a-Aminobenzenepropanenitrile

2-Amino-3-phenylpropanenitrile

CAS: 55379-75-4

Formula: C₉H₁₀N₂

Purity: 95%

Color and Shape: Solid

Molecular weight: 146.1891

Ref: IN-DA00DKKU

2-Amino-3-phenylpropanenitrile

CAS: 55379-75-4

Purity: 95%+

Molecular weight: 146.1929932

Ref: 10-F617065

2-Amino-3-phenylpropanenitrile

CAS: 55379-75-4

2-Amino-3-phenylpropanenitrile is an active form of a sulfoxide that has been shown to be effective in the treatment of brain tumors. It is chiral, with two enantiomers, and can be used as a diagnostic tool for the detection of brain tumors. The mechanism of action of 2-amino-3-phenylpropanenitrile is not fully understood, but it has been shown to have therapeutic effects on brain tumors in animal models. The stereoselective properties of this drug make it an attractive candidate for optimization and cancer treatment. Optimization studies have focused on the use of potassium t-butoxide in asymmetric synthesis, which may lead to improved therapeutic efficacy and reduced toxicity.

Formula: C₉H₁₀N₂

Purity: Min. 95%

Molecular weight: 146.19 g/mol

Ref: 3D-FCA37975